Precision Biosciences, Inc. · NASDAQ:DTIL
Aquilo Capital Management, LLC reported a 9.90% stake in Precision Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Aquilo Capital Management, LLC reported a 9.90% stake in Precision Biosciences, Inc., 791,862 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 791,862
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Aquilo Capital, L.P. | 6.60% | 521,372 |
| Aquilo Capital Management, LLC | 9.90% | 791,862 |
| Marc Schneidman | 9.90% | 791,862 |
Source
Related
- Precision Biosciences, Inc.
- Aquilo Capital, L.P.
- Precision Biosciences, Inc. shareholders
- Schedule 13G/A · Aquilo Capital, L.P. · Aug 6, 2025
- Form 4 · Frankel Stanley · Sep 30, 2026
- Form 4 · Brown Melinda · Sep 29, 2026
- Form 4 · Germano Geno J · Sep 29, 2026
- Schedule 13G/A · Weinstein Benjamin · Aug 24, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jul 29, 2026